# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-338052
Filing Date
2026-08-06
Accepted
2026-08-06 16:15:48
Documents
49
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | alec-20260630.htm iXBRL | 10-Q | 2278412
2 | EX-10.2 | alec-ex10_2.htm | EX-10.2 | 157356
3 | EX-31.1 | alec-ex31_1.htm | EX-31.1 | 22987
4 | EX-31.2 | alec-ex31_2.htm | EX-31.2 | 23001
5 | EX-32.1 | alec-ex32_1.htm | EX-32.1 | 9837
6 | EX-32.2 | alec-ex32_2.htm | EX-32.2 | 9824
| Complete submission text file | 0001193125-26-338052.txt |  | 6804456

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alec-20260630.xsd | EX-101.SCH | 662067
53 | EXTRACTED XBRL INSTANCE DOCUMENT | alec-20260630_htm.xml | XML | 1020787

Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 261249297
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)